PG
ALNY icon

PEAK6 Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

PEAK6 Group’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-5,400
Closed -$643K – 4252
2018
Q1 		$643K Sell
5,400
-32,100
-86% -$4.14M ﹤0.01% 2350
2017
Q4 		$4.76M Sell
37,500
-14,100
-27% -$1.77M 0.02% 841
2017
Q3 		$6.06M Buy
51,600
+34,100
+195% +$2.91M 0.03% 643
2017
Q2 		$1.4M Hold
17,500
– – 0.01% 1642
2017
Q1 		$897K Sell
17,500
-100
-0.6% -$4.62K 0.01% 1776
2016
Q4 		$659K Sell
17,600
-22,300
-56% -$934K ﹤0.01% 2245
2016
Q3 		$2.7M Buy
39,900
+16,100
+68% +$1.14M 0.02% 1070
2016
Q2 		$1.32M Buy
23,800
+16,700
+235% +$1.05M 0.01% 1571
2016
Q1 		$446K Buy
+7,100
New +$472K ﹤0.01% 2378
2015
Q4 		– Sell
-10,000
Closed -$804K – 4675
2015
Q3 		$804K Sell
10,000
-600
-6% -$66.7K ﹤0.01% 2430
2015
Q2 		$1.27M Buy
10,600
+7,600
+253% +$908K 0.01% 1866
2015
Q1 		$313K Sell
3,000
-13,100
-81% -$1.33M ﹤0.01% 3031
2014
Q4 		$1.56M Buy
16,100
+12,600
+360% +$1.17M 0.01% 1572
2014
Q3 		$273K Buy
+3,500
New +$226K ﹤0.01% 3027
2014
Q2 		– Sell
-5,000
Closed -$336K – 4565
2014
Q1 		$336K Buy
+5,000
New +$387K ﹤0.01% 2923
2013
Q4 		– Sell
-5,800
Closed -$371K – 4841
2013
Q3 		$371K Sell
5,800
-4,300
-43% -$214K ﹤0.01% 3086
2013
Q2 		$313K Buy
+10,100
New +$269K ﹤0.01% 3223

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

PEAK6 Group's ALNY Position: Q1 2018 in Review

PEAK6 Group sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2018, closing a stake of 25,752 shares — an estimated $3.32M sold.

PEAK6 Group first reported a position in ALNY in Q3 2014 and held it in 13 quarters. The position peaked at $4.13M in Q2 2015. 293 funds tracked by Wall St. Rank hold ALNY as of Q1 2018.

  • PEAK6 Group reported no remaining Alnylam Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • PEAK6 Group sold 25,752 Alnylam Pharmaceuticals shares in Q1 2018, an estimated $3.32M.
  • PEAK6 Group first reported a position in Alnylam Pharmaceuticals in Q3 2014 and held it in 13 quarters.
  • PEAK6 Group's Alnylam Pharmaceuticals position peaked at $4.13M in Q2 2015.
  • 293 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.